Mihaila R, Gheorghe A, Zob D, Stanculeanu D
Biomedicines. 2024; 12(9).
PMID: 39335659
PMC: 11429372.
DOI: 10.3390/biomedicines12092146.
Ito Y, Miyauchi A
Eur Thyroid J. 2024; 13(5).
PMID: 39213599
PMC: 11466271.
DOI: 10.1530/ETJ-24-0196.
Lee S, Koo B, Sun P, Yi S, Choi N, Yoon J
Cell Death Discov. 2024; 10(1):222.
PMID: 38719807
PMC: 11078953.
DOI: 10.1038/s41420-024-01970-z.
Balbaloglu H, Tasdoven I, Buyukuysal M, Karadeniz E, Comert M, Karadeniz Cakmak G
Ann Surg Treat Res. 2023; 105(5):290-296.
PMID: 38023432
PMC: 10648613.
DOI: 10.4174/astr.2023.105.5.290.
Ge J, Guo X, Zhao W, Zhang R, Bian Q, Luo L
Acta Endocrinol (Buchar). 2023; 19(2):215-220.
PMID: 37908873
PMC: 10614579.
DOI: 10.4183/aeb.2023.215.
Systemic immune-inflammation index: A new marker in differentiation of different thyroid diseases.
Vural S, Muhtaroglu A, Gungor M
Medicine (Baltimore). 2023; 102(31):e34596.
PMID: 37543770
PMC: 10402992.
DOI: 10.1097/MD.0000000000034596.
Is it Possible to Diagnose "Non-Invasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features" Preoperatively?.
Tazeoglu D, Dag A, Esmer A, Benli S, Arslan B, Bozdogan Arpaci R
Indian J Surg Oncol. 2023; 14(2):368-375.
PMID: 37324293
PMC: 10267065.
DOI: 10.1007/s13193-022-01696-3.
Role of Inflammatory Biomarkers (NLR, LMR, PLR) in the Prognostication of Malignancy in Indeterminate Thyroid Nodules.
Gambardella C, Mongardini F, Paolicelli M, Bentivoglio D, Cozzolino G, Ruggiero R
Int J Mol Sci. 2023; 24(7).
PMID: 37047439
PMC: 10094849.
DOI: 10.3390/ijms24076466.
Neutrophil-to-lymphocyte ratio as an independent factor for worse prognosis in radioiodine refractory thyroid cancer patients.
Treistman N, Cavalcante L, Gonzalez F, Fernandes P, de Andrade F, Garcis Alves-Junior P
Endocrine. 2023; 81(1):141-148.
PMID: 36905576
DOI: 10.1007/s12020-023-03340-8.
Evaluation of Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio and Mean Platelet Volume in Patients with Branchial Cleft Cyst.
Durgut O, Gokgun O, Gencay S
Indian J Otolaryngol Head Neck Surg. 2023; 74(Suppl 3):5465-5468.
PMID: 36742740
PMC: 9895673.
DOI: 10.1007/s12070-021-02789-1.
Preoperative platelet distribution width-to-platelet ratio combined with serum thyroglobulin may be objective and popularizable indicators in predicting papillary thyroid carcinoma.
Jin J, Wu G, Ruan C, Ling H, Zheng X, Ying C
J Clin Lab Anal. 2022; 36(6):e24443.
PMID: 35441746
PMC: 9169195.
DOI: 10.1002/jcla.24443.
Evaluation of LMR, NLR and PLR as predictors of malignancy in indeterminate thyroid nodules.
Offi C, Romano R, Cangiano A, Filograna Pignatelli M, Candela G, Docimo G
Acta Otorhinolaryngol Ital. 2021; 41(6):530-536.
PMID: 34928264
PMC: 8686799.
DOI: 10.14639/0392-100X-N1515.
Neutrophils to lymphocytes ratio between benign and malignant thyroid nodule.
Haider N, Mahmood Z, Khalid F, Razzak S
Pak J Med Sci. 2021; 37(7):1908-1911.
PMID: 34912416
PMC: 8613057.
DOI: 10.12669/pjms.37.7.4503.
Platelet Activation and Inflammation in Patients with Papillary Thyroid Cancer.
Martin S, Mustata T, Enache O, Ion O, Chifulescu A, Sirbu A
Diagnostics (Basel). 2021; 11(11).
PMID: 34829306
PMC: 8624142.
DOI: 10.3390/diagnostics11111959.
Assessment of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and mean platelet volume in patients with idiopathic epiretinal membrane.
Demir G, Topcu H, Cakmak S, Aksoy F, Sucu M, Gunes H
Ther Adv Ophthalmol. 2021; 13:25158414211010546.
PMID: 33997606
PMC: 8072817.
DOI: 10.1177/25158414211010546.
Serum Inflammation-based Scores in Endocrine Tumors.
Marques P, de Vries F, Dekkers O, Korbonits M, Biermasz N, Pereira A
J Clin Endocrinol Metab. 2021; 106(10):e3796-e3819.
PMID: 33837783
PMC: 8475227.
DOI: 10.1210/clinem/dgab238.
Clinical significance of neutrophil-to-lymphocyte ratio, lymphocyte-to-monocyte ratio, platelet-to-lymphocyte ratio and prognostic nutritional index in low-risk differentiated thyroid carcinoma.
Offi C, Romano R, Cangiano A, Candela G, Docimo G
Acta Otorhinolaryngol Ital. 2021; 41(1):31-38.
PMID: 33746220
PMC: 7982751.
DOI: 10.14639/0392-100X-N1089.
Prognostic Significance of Neutrophil-to-Lymphocyte Ratio in Differentiated Thyroid Carcinoma Having Distant Metastasis: A Comparison With Thyroglobulin-doubling Rate and Tumor Volume-doubling Rate.
Ito Y, Onoda N, Kihara M, Miya A, Miyauchi A
In Vivo. 2021; 35(2):1125-1132.
PMID: 33622910
PMC: 8045114.
DOI: 10.21873/invivo.12358.
Immune Cell Confrontation in the Papillary Thyroid Carcinoma Microenvironment.
Xie Z, Li X, He Y, Wu S, Wang S, Sun J
Front Endocrinol (Lausanne). 2020; 11:570604.
PMID: 33193087
PMC: 7642595.
DOI: 10.3389/fendo.2020.570604.
Delta Neutrophil Index and Neutrophil-to-Lymphocyte Ratio in the Differentiation of Thyroid Malignancy and Nodular Goiter.
Bozan M, Yazar F, Kale I, Yuzbasioglu M, Boran O, Azak Bozan A
World J Surg. 2020; 45(2):507-514.
PMID: 33067685
DOI: 10.1007/s00268-020-05822-6.